Adamantylmethamphetamine hydrochloride

Cat. No.: HY-116561 Purity: ≥98.0%: Data Sheet
COA

SDS
Handling Instructions
FAQs
Technical Support

Adamantylmethamphetamine hydrochloride is a psychotic compound, possessing a central action. Adamantylmethamphetamine hydrochloride has effects on hexobarbital sleeping time, spontaneous motor activity, and the potentiation of metrazole and antifatigue activity.

For research use only. We do not sell to patients.

Adamantylmethamphetamine hydrochloride Chemical Structure

CAS No. : 19835-42-8

Size	Stock	Quantity
5 mg	In-stock	Estimated Time of Arrival: December 31
10 mg	In-stock	Estimated Time of Arrival: December 31
25 mg	In-stock	Estimated Time of Arrival: December 31
50 mg	In-stock	Estimated Time of Arrival: December 31
100 mg	Get quote
200 mg	Get quote

or Bulk Inquiry

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Customer Review

Based on 1 publication(s) in Google Scholar

Featured Recommendations

•Related Small Molecules:

•Related Proteins:

Biological Activity
Purity & Documentation
References
Customer Review

Description	Adamantylmethamphetamine hydrochloride is a psychotic compound, possessing a central action. Adamantylmethamphetamine hydrochloride has effects on hexobarbital sleeping time, spontaneous motor activity, and the potentiation of metrazole and antifatigue activity^[1].
Molecular Weight	243.82
Formula	C₁₄H₂₆ClN
CAS No.	19835-42-8
Appearance	Solid
Color	White to off-white
SMILES	CC(NC)CC1(C[C@H](C2)C3)C[C@H]3C[C@H]2C1.Cl
Shipping	Room temperature in continental US; may vary elsewhere.
Storage	4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light)
Purity & Documentation	Purity: ≥98.0% Select Batch: Data Sheet (270 KB) SDS (251 KB) COA (254 KB) HNMR (249 KB) MS (136 KB) Handling Instructions (2659 KB)
References	[1]. De Angelis L, et al. Adamantylamphetamines: evaluation of their activity on the central nervous system. Farmaco Prat. 1976 May;31(5):227-37. [Content Brief]